Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of pregabalin in migraine prevention

Trial Profile

Efficacy of pregabalin in migraine prevention

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 11 May 2008

At a glance

  • Drugs Pregabalin (Primary) ; Valproate semisodium; Valproic acid
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2008 Status changed from initiated to withdrawn prior to recruitment, as reported by ClinicalTrials.gov.
    • 27 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top